137 related articles for article (PubMed ID: 8429830)
21. Modulation of the formation of the human amplification C3 convertase of complement by polycations.
Maillet F; Kazatchkine MD
Immunology; 1983 Sep; 50(1):27-33. PubMed ID: 6554235
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the mechanism of recognition in the complement alternative pathway using C3b-bound low molecular weight polysaccharides.
Pangburn MK
J Immunol; 1989 Apr; 142(8):2759-65. PubMed ID: 2467938
[TBL] [Abstract][Full Text] [Related]
23. The interaction of C3b bound to pneumococci with factor H (beta 1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system.
Brown EJ; Joiner KA; Gaither TA; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):409-15. PubMed ID: 6223077
[TBL] [Abstract][Full Text] [Related]
24. Potentiation of factor H by heparin: a rate-limiting mechanism for inhibition of the alternative complement pathway.
Boackle RJ; Caughman GB; Vesely J; Medgyesi G; Fudenberg HH
Mol Immunol; 1983 Nov; 20(11):1157-64. PubMed ID: 6228720
[TBL] [Abstract][Full Text] [Related]
25. Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis.
Sharma AK; Pangburn MK
Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10996-1001. PubMed ID: 8855297
[TBL] [Abstract][Full Text] [Related]
26. Control of the immune complex-complement interaction by protein H of the alternative complement pathway and the natural inhibitor heparin.
Spycher MO; Nydegger UE
Eur J Immunol; 1984 Mar; 14(3):276-9. PubMed ID: 6231187
[TBL] [Abstract][Full Text] [Related]
27. Analytic study of the differential anticomplementary effects of dextran sulphate and heparin in the assay for the mouse alternative pathway.
Klerx JP; Van Dijk H; Van der Maaden WJ; Willers JM
Int Arch Allergy Appl Immunol; 1985; 78(2):182-9. PubMed ID: 2412967
[TBL] [Abstract][Full Text] [Related]
28. Paroxysmal nocturnal hemoglobinuria: deficiency in factor H-like functions of the abnormal erythrocytes.
Pangburn MK; Schreiber RD; Trombold JS; Müller-Eberhard HJ
J Exp Med; 1983 Jun; 157(6):1971-80. PubMed ID: 6222136
[TBL] [Abstract][Full Text] [Related]
29. Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 Glomerulopathies.
Loeven MA; Maciej-Hulme ML; Yanginlar C; Hubers MC; Kellenbach E; de Graaf M; van Kuppevelt TH; Wetzels J; Rabelink TJ; Smith RJH; van der Vlag J
Front Immunol; 2021; 12():676662. PubMed ID: 34489931
[TBL] [Abstract][Full Text] [Related]
30. Regulation of the human alternative complement pathway: formation of a ternary complex between factor H, surface-bound C3b and chemical groups on nonactivating surfaces.
Carreno MP; Labarre D; Maillet F; Jozefowicz M; Kazatchkine MD
Eur J Immunol; 1989 Nov; 19(11):2145-50. PubMed ID: 2480904
[TBL] [Abstract][Full Text] [Related]
31. A new map of glycosaminoglycan and C3b binding sites on factor H.
Schmidt CQ; Herbert AP; Kavanagh D; Gandy C; Fenton CJ; Blaum BS; Lyon M; Uhrín D; Barlow PN
J Immunol; 2008 Aug; 181(4):2610-9. PubMed ID: 18684951
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylation of C3 by a casein kinase released from activated human platelets increases opsonization of immune complexes and binding to complement receptor type 1.
Nilsson-Ekdahl K; Nilsson B
Eur J Immunol; 2001 Apr; 31(4):1047-54. PubMed ID: 11298329
[TBL] [Abstract][Full Text] [Related]
33. Common binding region of complement factors B, H and CR1 on C3b revealed by monoclonal anti-C3d.
Koistinen V; Wessberg S; Leikola J
Complement Inflamm; 1989; 6(4):270-80. PubMed ID: 2527715
[TBL] [Abstract][Full Text] [Related]
34. Reduced activity of DAF on complement enzymes bound to alternative pathway activators. Similarity with Factor H.
Pangburn MK
Immunology; 1990 Dec; 71(4):598-600. PubMed ID: 1703989
[TBL] [Abstract][Full Text] [Related]
35. Alternative complement pathway activation fragment Ba binds to C3b. Evidence that formation of the factor B-C3b complex involves two discrete points of contact.
Pryzdial EL; Isenman DE
J Biol Chem; 1987 Feb; 262(4):1519-25. PubMed ID: 3643213
[TBL] [Abstract][Full Text] [Related]
36. A molecular insight into complement evasion by the staphylococcal complement inhibitor protein family.
Ricklin D; Tzekou A; Garcia BL; Hammel M; McWhorter WJ; Sfyroera G; Wu YQ; Holers VM; Herbert AP; Barlow PN; Geisbrecht BV; Lambris JD
J Immunol; 2009 Aug; 183(4):2565-74. PubMed ID: 19625656
[TBL] [Abstract][Full Text] [Related]
37. Polyanion-induced self-association of complement factor H.
Pangburn MK; Rawal N; Cortes C; Alam MN; Ferreira VP; Atkinson MA
J Immunol; 2009 Jan; 182(2):1061-8. PubMed ID: 19124749
[TBL] [Abstract][Full Text] [Related]
38. Regulation of the alternative pathway of human complement by C1q.
Fishelson Z; Müller-Eberhard HJ
Mol Immunol; 1987 Sep; 24(9):987-93. PubMed ID: 2958692
[TBL] [Abstract][Full Text] [Related]
39. Isolation of bovine complement factor H.
Mhatre A; Aston WP
Vet Immunol Immunopathol; 1987 Apr; 14(4):357-75. PubMed ID: 2955562
[TBL] [Abstract][Full Text] [Related]
40. Complement C3b/C3d and cell surface polyanions are recognized by overlapping binding sites on the most carboxyl-terminal domain of complement factor H.
Hellwage J; Jokiranta TS; Friese MA; Wolk TU; Kampen E; Zipfel PF; Meri S
J Immunol; 2002 Dec; 169(12):6935-44. PubMed ID: 12471127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
